Rare diseases
Investigational molecules
Locations
887 Patriot Drive Suite A, 93021-3355, United States
Advenchen Pharmaceuticals LLC demonstrates a focused commitment to addressing critical cardiovascular conditions through targeted therapeutic interventions. The company's research portfolio centers on developing treatments for patients experiencing acute and chronic cardiac events, with particular emphasis on conditions requiring immediate medical intervention and long-term management strategies.
The therapeutic approach encompasses both emergency cardiac care scenarios and sustained cardiovascular protection, reflecting an understanding of the complex pathophysiology underlying ischemic heart disease and the need for comprehensive treatment solutions across different stages of cardiac events.
Advenchen Pharmaceuticals LLC runs clinical trials in conditions such as Small cell lung cancer, Renal cell carcinoma, Non-small cell lung cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
